These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 27631358)

  • 1. Prevalence of 9-Valent Human Papillomavirus Types by Race/Ethnicity in the Prevaccine Era, United States, 2003-2006.
    Liu G; Unger ER; Hariri S; Steinau M; Markowitz LE
    Sex Transm Dis; 2016 Oct; 43(10):633-6. PubMed ID: 27631358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevaccine era human papillomavirus types 6, 11, 16 and 18 seropositivity in the U.S.A., National Health and Nutrition Examination Surveys, 2003-2006.
    Introcaso CE; Dunne EF; Hariri S; Panicker G; Unger ER; Markowitz LE
    Sex Transm Infect; 2014 Sep; 90(6):505-8. PubMed ID: 24748563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of human papillomavirus vaccination on racial/ethnic disparities in vaccine-type human papillomavirus prevalence among 14-26 year old females in the U.S.
    Hirth J; McGrath CJ; Kuo YF; Rupp RE; Starkey JM; Berenson AB
    Vaccine; 2018 Nov; 36(50):7682-7688. PubMed ID: 30377066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Declines in Vaccine-Type Human Papillomavirus Prevalence in Females Across Racial/Ethnic Groups: Data From a National Survey.
    McClung NM; Lewis RM; Gargano JW; Querec T; Unger ER; Markowitz LE
    J Adolesc Health; 2019 Dec; 65(6):715-722. PubMed ID: 31515134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution of Vaccine-Type Human Papillomavirus Does Not Differ by Race or Ethnicity Among Unvaccinated Young Women.
    Whittemore D; Ding L; Widdice LE; Brown DA; Bernstein DI; Franco EL; Kahn JA
    J Womens Health (Larchmt); 2016 Nov; 25(11):1153-1158. PubMed ID: 27754751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Individual and geographic disparities in human papillomavirus types 16/18 in high-grade cervical lesions: Associations with race, ethnicity, and poverty.
    Niccolai LM; Russ C; Julian PJ; Hariri S; Sinard J; Meek JI; McBride V; Markowitz LE; Unger ER; Hadler JL; Sosa LE
    Cancer; 2013 Aug; 119(16):3052-8. PubMed ID: 23661284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of and risk factors for oral human papillomavirus among young women in Costa Rica.
    Lang Kuhs KA; Gonzalez P; Struijk L; Castro F; Hildesheim A; van Doorn LJ; Rodriguez AC; Schiffman M; Quint W; Lowy DR; Porras C; Delvecchio C; Katki HA; Jimenez S; Safaeian M; Schiller J; Solomon D; Wacholder S; Herrero R; Kreimer AR;
    J Infect Dis; 2013 Nov; 208(10):1643-52. PubMed ID: 24014882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of Genital Human Papillomavirus by Age and Race/Ethnicity Among Males.
    Berenson AB; Hirth JM; Chang M
    Clin Infect Dis; 2021 Nov; 73(9):1625-1633. PubMed ID: 33983416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human papillomavirus in young women with Chlamydia trachomatis infection 7 years after the Australian human papillomavirus vaccination programme: a cross-sectional study.
    Chow EP; Danielewski JA; Fehler G; Tabrizi SN; Law MG; Bradshaw CS; Garland SM; Chen MY; Fairley CK
    Lancet Infect Dis; 2015 Nov; 15(11):1314-23. PubMed ID: 26201300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the polyclonal ELISA HPV serology assay as a biomarker for human papillomavirus exposure.
    Coseo SE; Porras C; Dodd LE; Hildesheim A; Rodriguez AC; Schiffman M; Herrero R; Wacholder S; Gonzalez P; Sherman ME; Jimenez S; Solomon D; Bougelet C; van Doorn LJ; Quint W; Safaeian M;
    Sex Transm Dis; 2011 Oct; 38(10):976-82. PubMed ID: 21934576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Declines in Prevalence of Human Papillomavirus Vaccine-Type Infection Among Females after Introduction of Vaccine - United States, 2003-2018.
    Rosenblum HG; Lewis RM; Gargano JW; Querec TD; Unger ER; Markowitz LE
    MMWR Morb Mortal Wkly Rep; 2021 Mar; 70(12):415-420. PubMed ID: 33764964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human papillomavirus (HPV) vaccination and oropharyngeal HPV in ethnically diverse, sexually active adolescents: community-based cross-sectional study.
    Kerry-Barnard S; Beddows S; Reid F; Beckley-Hoelscher N; Soldan K; Panwar K; Seran C; Fleming C; Lesniewska A; Planche T; Williamson J; Hay P; Oakeshott P
    Sex Transm Infect; 2021 Sep; 97(6):458-460. PubMed ID: 32883750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction in human papillomavirus (HPV) prevalence among young women following HPV vaccine introduction in the United States, National Health and Nutrition Examination Surveys, 2003-2010.
    Markowitz LE; Hariri S; Lin C; Dunne EF; Steinau M; McQuillan G; Unger ER
    J Infect Dis; 2013 Aug; 208(3):385-93. PubMed ID: 23785124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction in Vaccine-Type Human Papillomavirus Prevalence Among Women in the United States, 2009-2012.
    Berenson AB; Laz TH; Rahman M
    J Infect Dis; 2016 Dec; 214(12):1961-1964. PubMed ID: 27821406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human papillomavirus (HPV) 6, 11, 16, and 18 prevalence among females in the United States--National Health And Nutrition Examination Survey, 2003-2006: opportunity to measure HPV vaccine impact?
    Dunne EF; Sternberg M; Markowitz LE; McQuillan G; Swan D; Patel S; Unger ER
    J Infect Dis; 2011 Aug; 204(4):562-5. PubMed ID: 21791658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence, incidence, and natural history of HPV infection in adult women ages 24 to 45 participating in a vaccine trial.
    Ferris DG; Brown DR; Giuliano AR; Myers E; Joura EA; Garland SM; Kjaer SK; Perez G; Saah A; Luxembourg A; Velicer C
    Papillomavirus Res; 2020 Dec; 10():100202. PubMed ID: 32464334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human Papillomavirus (HPV) Prevalence in Male Adolescents 4 Years After HPV-16/18 Vaccination.
    Lehtinen T; Söderlund-Strand A; Petäjä T; Eriksson T; Jokiranta S; Natunen K; Dillner J; Lehtinen M
    J Infect Dis; 2017 Nov; 216(8):966-968. PubMed ID: 28968844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seroprevalence and correlates of human papillomavirus 16/18 seropositivity among young women in Costa Rica.
    Coseo S; Porras C; Hildesheim A; Rodriguez AC; Schiffman M; Herrero R; Wacholder S; Gonzalez P; Wang SS; Sherman ME; Jimenez S; Solomon D; Bougelet C; van Doorn LJ; Quint W; Safaeian M;
    Sex Transm Dis; 2010 Nov; 37(11):706-14. PubMed ID: 20661178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seroprevalence and Associated Factors of 9-Valent Human Papillomavirus (HPV) Types among Men in the Multinational HIM Study.
    Rahman S; Pierce Campbell CM; Rollison DE; Wang W; Waterboer T; Michel A; Pawlita M; Villa LL; Lazcano Ponce E; Borenstein AR; Giuliano AR
    PLoS One; 2016; 11(11):e0167173. PubMed ID: 27902759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Human papillomavirus prophylactic vaccines: stakes and perspectives].
    Hantz S; Alain S; Denis F
    Gynecol Obstet Fertil; 2006; 34(7-8):647-55. PubMed ID: 16807045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.